MetaVia (NASDAQ:MTVA) Stock Price Up 3.9% – What’s Next?

MetaVia Inc. (NASDAQ:MTVA)’s share price shot up 3.9% on Monday . The company traded as high as $0.74 and last traded at $0.72. 128,750 shares traded hands during trading, a decline of 69% from the average session volume of 412,726 shares. The stock had previously closed at $0.69.

Wall Street Analyst Weigh In

MTVA has been the subject of several recent analyst reports. Maxim Group decreased their target price on MetaVia from $6.00 to $3.00 and set a “buy” rating for the company in a research note on Monday, May 19th. HC Wainwright reaffirmed a “buy” rating and issued a $12.00 price target on shares of MetaVia in a research report on Wednesday, April 16th.

MetaVia Price Performance

The company has a 50 day simple moving average of $0.88.

MetaVia (NASDAQ:MTVA) last posted its quarterly earnings results on Wednesday, May 14th. The company reported ($0.36) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.57) by $0.21. On average, equities analysts expect that MetaVia Inc. will post -3.9 EPS for the current year.

MetaVia Company Profile

MetaVia Inc is a clinical-stage biotechnology company focused on transforming cardiometabolic diseases. MetaVia Inc, formerly known as NeuroBo Pharmaceuticals Inc, is based in CAMBRIDGE, Mass.